PRTODAY / NewswireToday Free press release distribution service network

Written by / Agency / Source: Sentrx

Check Ads Availability|e-mail Article


Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!

Sentrx Enhances Performance Management Metrics - Sentrx announces it has augmented the key performance metrics associated with its SaPh Cloud Solution with internet-based metrics that provide 24/7 mission-critical remote availability monitoring and performance measurement - Sentrx.com
Sentrx Enhances Performance Management Metrics

 

NewswireToday - /newswire/ - Little Falls, NJ, United States, 2011/10/18 - Sentrx announces it has augmented the key performance metrics associated with its SaPh Cloud Solution with internet-based metrics that provide 24/7 mission-critical remote availability monitoring and performance measurement - Sentrx.com.

   
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma/BioTech/Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Sentrx, the leading provider of drug safety services to the life sciences industry, is pleased to announce it has augmented the breadth and depth of key performance metrics associated with its SaPh™ Cloud Solution. The internet-based metrics provide 24/7 mission-critical remote availability monitoring and performance measurement as part of the company’s SaPh™ Cloud Solution. This service ensures that their SRAS system performance is within industry standards. The metrics offer both summary level and highly detailed level reporting on a wide variety of indicators important to a hosted user experience.

“Sentrx has been a leader in moving regulated technology applications into the cloud, and the updated reporting metrics are part of our continued commitment to ensure clients that our SaPh™ solution creates the most efficient and effective work environment for remote pharmacovigilance users,” said Michael O’Gorman, President and General Manager.

The Sentrx SaPh™ Cloud Solution is a regulated, ASP based approach to drug safety database management, specifically engineered to support power users of safety systems. The Sentrx SaPh™ Cloud Solution includes all the tools and services required for the effective and highly efficient management of safety systems including implementation, configuration, validation and continuous support. Sentrx considers SaPh™ an ideal solution for those companies who seek to efficiently centralize safety data management across all users, and for all types of pharmacovigilance events at any phase of a company’s lifecycle.

About Sentrx

Sentrx (sentrx.com) is an industry leader in providing outsourced drug safety solutions comprehensive pharmacovigilance solutions. Developing from a strong foundation in adverse event case processing and related drug data system management, the company has the most experienced and expertise personnel in the full-spectrum of drug safety solutions. Sentrx integrates business process outsourcing solutions, with a focus on providing flexible and scalable solutions, backed by the Sentrx Technology Services Group (TSG) with proven tools and technology platforms, Sentrx is safety.

Submitted by Logarithmic IMPACT (LogarithmicIMPACT.com) on behalf of Sentrx.

 
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma/BioTech/Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Written by / Agency / Source: Sentrx

 
 

Availability: All Regions (Including Int'l)

 

Traffic Booster: [/] Quick Newswire Today Visibility Checker

 

Distribution / Indexing: [+] / [Company listed above is a registered member of our network. Content made possible by PRZOOM / PRTODAY indexing services]

 
 
# # #
 

 
  Your Banner Ad showing on ALL
Pharma/BioTech/Nutrition articles,
CATCH Visitors via Your Competitors Announcements!


Sentrx Enhances Performance Management Metrics

Company website links NOT available to basic submissions
It is OK to republish and/or LINK any newswire for any legitimate media purpose as long as you name Newswire Today and LINK as the source.
 
  Is this your article?
Activate ALL web links and social stream by Upgrading to Press Release PREMIUM Plan Now!

|
Publisher Contact: Michael O'Gorman - Sentrx.com 
973-826-1881 Michael.Ogorman[.]sentrx.com
 
Newswire Today - PRZOOM / PRTODAY disclaims any content contained in this article. If you need/wish to contact the company who published the current release, you will need to contact them - NOT us. Issuers of articles are solely responsible for the accuracy of their content. Our complete disclaimer appears here.
IMPORTANT INFORMATION: Issuance, publication or distribution of this press release in certain jurisdictions could be subject to restrictions. The recipient of this press release is responsible for using this press release and the information herein in accordance with the applicable rules and regulations in the particular jurisdiction. This press release does not constitute an offer or an offering to acquire or subscribe for any Sentrx securities in any jurisdiction including any other companies listed or named in this release.

Pharma/BioTech/Nutrition via RSSAdd NewswireToday - PRZOOM Headline News to FeedBurner
Find who RetweetFollow @NewswireTODAY



Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!


Read Latest Articles From Sentrx / Company Profile


Read Pharma/BioTech/Nutrition Most Recent Related Newswires:

BD Expands Suite of Blood Culture Offerings with New BD BACTEC™ Standard Aerobic & Standard Anaerobic Plastic Bottles
Twist Bioscience Collaborates with Synbio Technologies to Supply Long DNA to Customers
FDA Grants Priority Review and Breakthrough Therapy Designation for Zelboraf (vemurafenib) in Erdheim-Chester Disease with BRAF V600 Mutation
Ipsen Receives Positive CHMP Opinion for Approval of Xermelo® (telotristat Ethyl)
BD Receives FDA 510(k) Clearance for New Immunological Diagnostic System
Positive Phase III Results for Genentech’s Emicizumab in Hemophilia A Published in The New England Journal of Medicine
Somatuline® Autogel® 120 Mg Receives Japanese Approval for A New Indication for the Treatment of Gastro-entero-pancreatic Neuroendocrine Tumors
OTC Topical Drugs Market Size will Grow Profitably in the Near Future 2017-2025 Finds PMR
Bioinformatics Market Size to Expand at 20.4% CAGR through 2020 Reports Persistence Market Research
Australia Nitric Acid Market Expected to Reach at Value of $1.3B by 2024 End Says PMR
Commodity Chemicals Market Projected to be Resilient by 2020 Says Persistence Market Research
Cell Expansion Market Set to Garner Staggering Revenues by 2025 Reports PMR
Soft Tissue Sarcoma Treatment Market Revenue Predicted To Go Up by 2025 Finds Persistence Market Research
Persistence Market Research Publishes Biopharmaceutical Membrane Filtration Market Forecast Over 2017-2025
Global Tablet Processing & Packaging Equipment Market to Reach USD 5,268.8 Million by 2022

Boost Your Social Network
& Crowdfunding Campaigns


LIFETIME SOCIAL MEDIA WALL
NewswireToday Celebrates 10 Years in Business


PREMIUM Members


Visit  JobsWare.com

Visit  NAKIVO, Inc.





 
  ©2017 Newswire Today — Limelon Advertising, Co.
Home | About | Advertise/Pricing | Contact | Investors | Privacy/TOS | Sitemap | FRANCAIS
newswire, PR press releases distribution service magazines engine news alert newsroom press room breaking news public relations articles company news alerts newswiredistribution ezine bizentrepreneur biznewstoday digital business report market search pr firms agencies reports distri-bution today investor relation successful internet entrepreneurs newswire distribution prtoday.com freenewswiredistribution asianewstoday bizwiretoday USA pr UK today - NOT affiliated with PRNewswire as we declined their partnership offer in 2013
 
PRTODAY & NewswireTODAY are NOT affiliated with USA TODAY (usatoday.com)